Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Buy
61
SMWB Quote, Financials, Valuation and Earnings
Last price:
$8.47
Seasonality move
:
-2.22%
Day range:
$8.11 - $8.49
52-week range:
$5.71 - $17.64
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
2.65x
P/B ratio:
29.12x
Volume:
842.6K
Avg. volume:
513.9K
1-year change:
16.11%
Market cap:
$698.4M
Revenue:
$249.9M
EPS (TTM):
-$0.22
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $93.5M | $137.7M | $193.2M | $218M | $249.9M | |
| Revenue Growth (YoY) | 32.44% | 47.26% | 40.36% | 12.83% | 14.63% | |
| Cost of Revenues | $21.4M | $31.8M | $53.3M | $47.1M | $54.8M | |
| Gross Profit | $72.1M | $105.9M | $140M | $170.9M | $195.1M | |
| Gross Profit Margin | 77.09% | 76.94% | 72.43% | 78.4% | 78.07% | |
| R&D Expenses | $22.1M | $44.4M | $59.9M | $56.2M | $55.6M | |
| Selling, General & Admin | $69.7M | $127.6M | $167.9M | $143.6M | $149.2M | |
| Other Inc / (Exp) | -- | -- | $290K | -- | -- | |
| Operating Expenses | $91.7M | $172M | $227.8M | $199.7M | $204.8M | |
| Operating Income | -$19.7M | -$66.1M | -$87.9M | -$28.8M | -$9.7M | |
| Net Interest Expenses | $1.7M | $1.9M | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$21.4M | -$68M | -$83.1M | -$27.9M | -$9.5M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $640K | $981K | $516K | $1.5M | $1.9M | |
| Net Income to Company | -$22M | -$69M | -$83.7M | -$29.4M | -$11.5M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$22M | -$69M | -$83.7M | -$29.4M | -$11.5M | |
| Basic EPS (Cont. Ops) | -$0.35 | -$1.30 | -$1.10 | -$0.38 | -$0.14 | |
| Diluted EPS (Cont. Ops) | -$0.35 | -$1.30 | -$1.10 | -$0.38 | -$0.14 | |
| Weighted Average Basic Share | $66.1M | $53.2M | $75.7M | $77.8M | $80.8M | |
| Weighted Average Diluted Share | $66.1M | $53.2M | $75.7M | $77.8M | $80.8M | |
| EBITDA | -$17.7M | -$62.9M | -$77.3M | -$18.5M | $864K | |
| EBIT | -$19.7M | -$66.1M | -$87.9M | -$28.8M | -$9.7M | |
| Revenue (Reported) | $93.5M | $137.7M | $193.2M | $218M | $249.9M | |
| Operating Income (Reported) | -$19.7M | -$66.1M | -$87.9M | -$28.8M | -$9.7M | |
| Operating Income (Adjusted) | -$19.7M | -$66.1M | -$87.9M | -$28.8M | -$9.7M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $29.4M | $44.3M | $52.8M | $59M | $67.1M | |
| Revenue Growth (YoY) | 42.78% | 50.55% | 19.13% | 11.81% | 13.74% | |
| Cost of Revenues | $6.3M | $13.1M | $12.1M | $12.7M | $14M | |
| Gross Profit | $23.1M | $31.2M | $40.7M | $46.3M | $53.1M | |
| Gross Profit Margin | 78.67% | 70.43% | 77.11% | 78.48% | 79.18% | |
| R&D Expenses | $9M | $14.7M | $14.4M | $13.5M | $18M | |
| Selling, General & Admin | $25.7M | $42.7M | $39.4M | $35.4M | $44.4M | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | $34.7M | $57.4M | $53.8M | $49M | $62.4M | |
| Operating Income | -$11.6M | -$26.2M | -$13.1M | -$2.7M | -$9.3M | |
| Net Interest Expenses | $347K | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$11.9M | -$25.4M | -$11.7M | -$2.2M | -$8.3M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $216K | $250K | $109K | $504K | $975K | |
| Net Income to Company | -$12.1M | -$25.6M | -$11.8M | -$2.7M | -$9.3M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$12.1M | -$25.6M | -$11.8M | -$2.7M | -$9.3M | |
| Basic EPS (Cont. Ops) | -$0.16 | -$0.34 | -$0.15 | -$0.03 | -$0.11 | |
| Diluted EPS (Cont. Ops) | -$0.16 | -$0.34 | -$0.15 | -$0.03 | -$0.11 | |
| Weighted Average Basic Share | $74.3M | $75M | $76.9M | $79.4M | $83.1M | |
| Weighted Average Diluted Share | $74.3M | $75M | $76.9M | $79.4M | $83.1M | |
| EBITDA | -$11M | -$23.1M | -$10.5M | -$164K | -$7.2M | |
| EBIT | -$11.6M | -$26.2M | -$13.1M | -$2.7M | -$9.3M | |
| Revenue (Reported) | $29.4M | $44.3M | $52.8M | $59M | $67.1M | |
| Operating Income (Reported) | -$11.6M | -$26.2M | -$13.1M | -$2.7M | -$9.3M | |
| Operating Income (Adjusted) | -$11.6M | -$26.2M | -$13.1M | -$2.7M | -$9.3M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $102.3M | $152.5M | $201.7M | $224.3M | $258M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $22.5M | $38.6M | $52.3M | $47.7M | $56.1M | |
| Gross Profit | $79.8M | $114M | $149.4M | $176.5M | $201.9M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $26.2M | $50.1M | $59.5M | $55.3M | $60.1M | |
| Selling, General & Admin | $79M | $144.6M | $164.7M | $139.6M | $158.1M | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | $105.2M | $194.7M | $224.2M | $195M | $218.2M | |
| Operating Income | -$25.5M | -$80.7M | -$74.8M | -$18.4M | -$16.3M | |
| Net Interest Expenses | $1.7M | $722K | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$27.1M | -$81.5M | -$69.5M | -$18.4M | -$15.6M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $789K | $1M | $375K | $1.9M | $2.4M | |
| Net Income to Company | -$27.9M | -$82.5M | -$69.9M | -$20.3M | -$18M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$27.9M | -$82.5M | -$69.9M | -$20.3M | -$18M | |
| Basic EPS (Cont. Ops) | -$0.41 | -$1.22 | -$0.92 | -$0.25 | -$0.22 | |
| Diluted EPS (Cont. Ops) | -$0.41 | -$1.22 | -$0.92 | -$0.25 | -$0.22 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | -$23.5M | -$75M | -$64.7M | -$8.2M | -$6.2M | |
| EBIT | -$25.5M | -$80.7M | -$74.8M | -$18.4M | -$16.3M | |
| Revenue (Reported) | $102.3M | $152.5M | $201.7M | $224.3M | $258M | |
| Operating Income (Reported) | -$25.5M | -$80.7M | -$74.8M | -$18.4M | -$16.3M | |
| Operating Income (Adjusted) | -$25.5M | -$80.7M | -$74.8M | -$18.4M | -$16.3M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $29.4M | $44.3M | $52.8M | $59M | $67.1M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $6.3M | $13.1M | $12.1M | $12.7M | $14M | |
| Gross Profit | $23.1M | $31.2M | $40.7M | $46.3M | $53.1M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $9M | $14.7M | $14.4M | $13.5M | $18M | |
| Selling, General & Admin | $25.7M | $42.7M | $39.4M | $35.4M | $44.4M | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | $34.7M | $57.4M | $53.8M | $49M | $62.4M | |
| Operating Income | -$11.6M | -$26.2M | -$13.1M | -$2.7M | -$9.3M | |
| Net Interest Expenses | $347K | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$11.9M | -$25.4M | -$11.7M | -$2.2M | -$8.3M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $216K | $250K | $109K | $504K | $975K | |
| Net Income to Company | -$12.1M | -$25.6M | -$11.8M | -$2.7M | -$9.3M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$12.1M | -$25.6M | -$11.8M | -$2.7M | -$9.3M | |
| Basic EPS (Cont. Ops) | -$0.16 | -$0.34 | -$0.15 | -$0.03 | -$0.11 | |
| Diluted EPS (Cont. Ops) | -$0.16 | -$0.34 | -$0.15 | -$0.03 | -$0.11 | |
| Weighted Average Basic Share | $74.3M | $75M | $76.9M | $79.4M | $83.1M | |
| Weighted Average Diluted Share | $74.3M | $75M | $76.9M | $79.4M | $83.1M | |
| EBITDA | -$11M | -$23.1M | -$10.5M | -$164K | -$7.2M | |
| EBIT | -$11.6M | -$26.2M | -$13.1M | -$2.7M | -$9.3M | |
| Revenue (Reported) | $29.4M | $44.3M | $52.8M | $59M | $67.1M | |
| Operating Income (Reported) | -$11.6M | -$26.2M | -$13.1M | -$2.7M | -$9.3M | |
| Operating Income (Adjusted) | -$11.6M | -$26.2M | -$13.1M | -$2.7M | -$9.3M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $23.9M | $128.9M | $77.8M | $71.7M | $63.9M | |
| Short Term Investments | $30M | -- | -- | -- | -- | |
| Accounts Receivable, Net | $25.3M | $31M | $38.1M | $47.9M | $51M | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | $1.2M | $2.9M | $3.5M | $2.8M | $3.2M | |
| Other Current Assets | $397K | -- | $177K | $456K | $282K | |
| Total Current Assets | $88.2M | $187.7M | $142.2M | $146.4M | $141.4M | |
| Property Plant And Equipment | $6.1M | $6.4M | $72.6M | $64.6M | $60.3M | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | $2.9M | $11.3M | $12.9M | $12.9M | $25.3M | |
| Other Intangibles | -- | $11.6M | $9.6M | $4.8M | $5.6M | |
| Other Long-Term Assets | $401K | $813K | $441K | $494K | $500K | |
| Total Assets | $103.6M | $227M | $246M | $239M | $242.9M | |
| Accounts Payable | $4.3M | $11.3M | $7.1M | $8.4M | $12.4M | |
| Accrued Expenses | $15.7M | $23.9M | $25.8M | $29.2M | $30.6M | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | $9.1M | $7.1M | $6.9M | |
| Other Current Liabilities | -- | -- | $346K | -- | $29K | |
| Total Current Liabilities | $108.4M | $134.1M | $180.9M | $184.2M | $177.2M | |
| Long-Term Debt | -- | -- | -- | -- | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $112.9M | $142.1M | $224.1M | $223.5M | $215.4M | |
| Common Stock | $135.9M | $205K | $210K | $216K | $227K | |
| Other Common Equity Adj | $76K | $160K | -$367K | $872K | $388K | |
| Common Equity | -$145.1M | $84.9M | $22M | $15.5M | $27.5M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | -$9.3M | $84.9M | $22M | $15.5M | $27.5M | |
| Total Liabilities and Equity | $103.6M | $227M | $246M | $239M | $242.9M | |
| Cash and Short Terms | $53.9M | $128.9M | $77.8M | $71.7M | $63.9M | |
| Total Debt | $26.9M | -- | $25M | $25M | -- | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $38.3M | $125M | $75.3M | $54.9M | $59.6M | |
| Short Term Investments | $20M | -- | -- | -- | -- | |
| Accounts Receivable, Net | $24.3M | $30.5M | $37.5M | $41.3M | $40M | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | $1M | $11M | -- | -- | -- | |
| Other Current Assets | $538K | -- | $5M | $6.4M | $5.6M | |
| Total Current Assets | $92.9M | $187.5M | $137.1M | $123.8M | $126.9M | |
| Property Plant And Equipment | $6M | $60.8M | $71M | $64.4M | $60.3M | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | $2.9M | $11.3M | $12.9M | -- | -- | |
| Other Intangibles | -- | $10.6M | $8.4M | -- | -- | |
| Other Long-Term Assets | $1.7M | $813K | $10K | $461K | $737K | |
| Total Assets | $110.1M | $281M | $236.7M | $219.4M | $237.7M | |
| Accounts Payable | $6.3M | $27M | $6.1M | $6M | $9.6M | |
| Accrued Expenses | $16.5M | $20.3M | $16.4M | $15.8M | $19.1M | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | $504K | $8.4M | $6.4M | $8M | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $124.8M | $165.8M | $180.7M | $161.6M | $174.8M | |
| Long-Term Debt | -- | -- | -- | -- | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $128.5M | $216.7M | $221M | $200.3M | $213.7M | |
| Common Stock | $135.9M | $207K | $212K | $221K | $229K | |
| Other Common Equity Adj | -$184K | $246K | -$644K | $355K | -$354K | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | -$18.4M | $64.3M | $15.7M | $19.1M | $24M | |
| Total Liabilities and Equity | $110.1M | $281M | $236.7M | $219.4M | $237.7M | |
| Cash and Short Terms | $58.3M | $125M | $75.3M | $54.9M | $59.6M | |
| Total Debt | $30M | -- | $25M | -- | -- | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$22M | -$69M | -$83.7M | -$29.4M | -$11.5M | |
| Depreciation & Amoritzation | $2M | $3.2M | $10.6M | $10.3M | $10.5M | |
| Stock-Based Compensation | $4.8M | $11.2M | $17M | $18.1M | $17.6M | |
| Change in Accounts Receivable | -$6.6M | -$5.1M | -$6.9M | -$9.7M | -$2.1M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$3.8M | -$27.6M | -$46.1M | -$3M | $30.2M | |
| Capital Expenditures | $1.1M | $3.1M | $31.2M | $2.4M | $2.7M | |
| Cash Acquisitions | -- | -$9.5M | -$3.5M | -- | -$15.4M | |
| Cash From Investing | -$30.8M | $7.4M | -$33M | -$2.6M | -$18.7M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $11.8M | $30M | $25M | -- | -- | |
| Long-Term Debt Repaid | -$1.8M | -$56.9M | -- | -- | -$25M | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -$2.4M | -- | |
| Cash From Financing | $51.2M | $125.2M | $29.1M | $1.2M | -$18.8M | |
| Beginning Cash (CF) | $7M | $23.9M | $128.9M | $77.8M | $71.7M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $16.7M | $105M | -$50M | -$4.4M | -$7.4M | |
| Ending Cash (CF) | $23.9M | $128.9M | $77.8M | $71.7M | $63.9M | |
| Levered Free Cash Flow | -$4.9M | -$30.7M | -$77.2M | -$5.4M | $27.4M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$12.1M | -$25.6M | -$11.8M | -$2.7M | -$9.3M | |
| Depreciation & Amoritzation | $520K | $3M | $2.5M | $2.5M | $2.1M | |
| Stock-Based Compensation | $2.9M | $3.8M | $4.4M | $4.1M | $5.8M | |
| Change in Accounts Receivable | $925K | $486K | $644K | $7M | $11.8M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $2.3M | $914K | $326K | $10.1M | $4.9M | |
| Capital Expenditures | $451K | $5.2M | $1.6M | $364K | $501K | |
| Cash Acquisitions | -- | -- | -- | -$3.8M | -$9.3M | |
| Cash From Investing | $9M | -$5.2M | -$1.6M | -$4.3M | -$9.9M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $30M | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -$26.8M | -- | -- | -$25M | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$387K | -- | -$2.4M | -- | -- | |
| Cash From Financing | $3.2M | $609K | -$971K | -$22.3M | $562K | |
| Beginning Cash (CF) | $23.9M | $128.9M | $77.8M | $71.7M | $63.9M | |
| Foreign Exchange Rate Adjustment | -$149K | -$231K | -$207K | -$236K | $160K | |
| Additions / Reductions | $14.5M | -$3.6M | -$2.3M | -$16.6M | -$4.5M | |
| Ending Cash (CF) | $38.3M | $125M | $75.3M | $54.9M | $59.6M | |
| Levered Free Cash Flow | $1.9M | -$4.3M | -$1.2M | $9.7M | $4.4M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$27.9M | -$82.5M | -$69.9M | -$20.3M | -$18M | |
| Depreciation & Amoritzation | $1.9M | $5.7M | $10.1M | $10.2M | $10.1M | |
| Stock-Based Compensation | $7.2M | $12.1M | $17.6M | $17.8M | $19.3M | |
| Change in Accounts Receivable | -$9.5M | -$5.6M | -$6.7M | -$3.4M | $2.6M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$2M | -$29M | -$46.7M | $6.7M | $25M | |
| Capital Expenditures | $1.4M | $7.8M | $27.6M | $1.2M | $2.9M | |
| Cash Acquisitions | -- | -$9.5M | -$3.5M | -$3.8M | -$20.9M | |
| Cash From Investing | -$21.9M | -$6.8M | -$29.5M | -$5.3M | -$24.3M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $31.8M | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -$28.6M | -- | -- | -- | $25M | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | $43.9M | $122.7M | $27.5M | -$20.2M | $4.1M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $20.1M | $86.8M | -$48.6M | -$18.8M | $4.8M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -$3.3M | -$36.9M | -$74.2M | $5.5M | $22.1M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$12.1M | -$25.6M | -$11.8M | -$2.7M | -$9.3M | |
| Depreciation & Amoritzation | $520K | $3M | $2.5M | $2.5M | $2.1M | |
| Stock-Based Compensation | $2.9M | $3.8M | $4.4M | $4.1M | $5.8M | |
| Change in Accounts Receivable | $925K | $486K | $644K | $7M | $11.8M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $2.3M | $914K | $326K | $10.1M | $4.9M | |
| Capital Expenditures | $451K | $5.2M | $1.6M | $364K | $501K | |
| Cash Acquisitions | -- | -- | -- | -$3.8M | -$9.3M | |
| Cash From Investing | $9M | -$5.2M | -$1.6M | -$4.3M | -$9.9M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $30M | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -$26.8M | -- | -- | -$25M | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$387K | -- | -$2.4M | -- | -- | |
| Cash From Financing | $3.2M | $609K | -$971K | -$22.3M | $562K | |
| Beginning Cash (CF) | $23.9M | $128.9M | $77.8M | $71.7M | $63.9M | |
| Foreign Exchange Rate Adjustment | -$149K | -$231K | -$207K | -$236K | $160K | |
| Additions / Reductions | $14.5M | -$3.6M | -$2.3M | -$16.6M | -$4.5M | |
| Ending Cash (CF) | $38.3M | $125M | $75.3M | $54.9M | $59.6M | |
| Levered Free Cash Flow | $1.9M | -$4.3M | -$1.2M | $9.7M | $4.4M | |
Get SMWB Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
SMWB
Sector
P/E ratio
--
23.75x
PEG ratio
--
0.00x
P/B ratio
29.12x
2.35x
Price / LTM sales
2.65x
1.66x
Growth Metrics
SMWB
Sector
Revenue growth
13.74%
3.91%
Earnings growth
--
11.1%
Revenue (5-year growth)
28.77%
6.27%
Earnings forecast
-$0.01
$0.12
Profitability
SMWB
Sector
Profitability FY 2024
$195.1M
$76.5M
Return on invested capital
-74.79%
0.05%
Return on assets
-7.83%
-0.48%
Return on equity
-74.79%
0.73%
Earnings Date
Last Earnings Date
May
13
Next Earnings Date
Aug
6
Estimated Next Earnings Date
Aug
12
Balance Sheet
SMWB
Sector
Total cash
$59.6M
$48.7M
Short term investments
--
$19.4M
Total assets
$242.9M
$223.8M
Long term debt
--
$6M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
71
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 59x
Buy
51
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
68
MCRI alert for Jul 18
Monarch Casino & Resort [MCRI] is up 19.81% over the past day.
Sell
41
NEGG alert for Jul 18
Newegg Commerce [NEGG] is up 17.85% over the past day.
Buy
72
MNPR alert for Jul 18
Monopar Therapeutics [MNPR] is up 13.2% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
